
Carnival: Analysts' New Targets, Estimates
Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
) --
Abercrombie & Fitch
(ANF) - Get Report
numbers raised through 2012 at Citigroup. Company continues to see healthy comp sales growth.
Carnival
(CCL) - Get Report
price target increased at Citigroup to $56. Company should see improving pricing power, Citigroup said. Buy rating.
Cintas
(CTAS) - Get Report
estimates raised through 2012 at Citigroup. New clients are driving sales growth, Citigroup said. Hold rating and $29 price target.
Danaher
(DHR) - Get Report
price target raised at Citigroup to $56. Company has an upbeat outlook for the new year, Citigroup said. Buy rating.
Medtronic
(MDT) - Get Report
price target boosted to $47 at Citigroup. Company has new management and should benefit from a higher industry multiple. Buy rating.
Nike
(NKE) - Get Report
2011 and 2012 EPS estimates lowered at Credit Suisse to $4.35 and $4.85, respectively. 150-basis-point margin pressure due to cost inflation, Credit Suisse said. Maintain Outperform rating and $100 price target.
Nike
(NKE) - Get Report
estimates, target boosted at Morgan Stanley. Shares now seen reaching $94. Estimates are also upped, as strong futures orders are driving increased earnings visibility, Morgan Stanley said. Overweight rating.
Paychex
(PAYX) - Get Report
price target raised to $29 at Credit Suisse. Solid 2Q11 results and optimistic outlook, Credit Suisse said. Estimates raised through 2013. Maintain Neutral rating.
Red Hat
(RHT) - Get Report
price target raised to $48 from $36 at Barclays. Broad strength is driving third-quarter billings upside, Barclays said. 2011 and 2012 EPS estimates lifted to $0.79 and $0.95, respectively. Maintain Equal Weight rating.
Riverbed Technology
(RVBD)
price target boosted at Barclays to $50 from $40. Another beat-and-raise story, and robust demand continues, Barclays said. Reiterate Overweight rating.
Texas Instruments
(TXN) - Get Report
numbers raised at UBS. Shares now seen reaching $32. Estimates also increased, given better demand for smartphones and communications infrastructure. Neutral rating.
UnitedHealth Group
(UNH) - Get Report
target, estimates boosted at Credit Suisse. Price target raised by a dollar to $48. 2010 and 2011 EPS estimates lifted to $4.05 and $3.75, respectively. Weaker cost trends, and selloff on RADV Audit overdone, Credit Suisse said. Maintain Outperform rating.
Xilinx
(XLNX) - Get Report
estimates lowered at UBS through 2013. Company is seeing a delay in European orders. Neutral rating and $28 price target.
This article was written by a staff member of TheStreet.









